Weed (BUDZ) Net Cash Flow (2010 - 2026)
Weed's (BUDZ) quarterly Net Cash Flow came in at -$28537.0 in Q1 2026, up 81.72% year-on-year from -$15703.6 in Q1 2025, and down 187.17% quarter-over-quarter from $32738.0 in Q4 2025.
Weed (BUDZ) Net Cash Flow (2010 - 2026) Analysis & Trends
Weed's Net Cash Flow history runs 13 years deep, the most recent figure standing at -$28537.0 for Q1 2026.
- On a quarterly basis, Net Cash Flow rose 81.72% year-over-year to -$28537.0 in Q1 2026; TTM through Mar 2026 was $2568.0, a 102.6% increase from a year earlier, with the FY2025 full-year figure at -$125033.0, up 4.01% from the prior year.
- Net Cash Flow slipped to -$28537.0 in Q1 2026 per BUDZ's latest filing, from $32738.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $659869.0 in Q3 2023 and bottomed at -$472140.0 in Q2 2022.
- The 5-year median for Net Cash Flow is -$86721.0 (2024), against an average of -$75085.9.
- Across the five-year window, Net Cash Flow sank 8967.41% in 2022 and surged 332.15% in 2023, its largest moves.
- Year by year, Net Cash Flow stood at -$220249.0 in 2022, then slumped by 61.13% to -$354885.0 in 2023, then jumped by 143.37% to $153899.0 in 2024, then slumped by 78.73% to $32738.0 in 2025, then tumbled by 187.17% to -$28537.0 in 2026.
- Per Business Quant, the three latest BUDZ Net Cash Flow figures stand at -$28537.0 (Q1 2026), $32738.0 (Q4 2025), and -$4952.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | -28,537.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28,537.00 |
| Mar 31, 2026 | -28,537.00 |
| Dec 31, 2025 | 32,738.00 |
| Dec 31, 2025 | 32,738.00 |
| Sep 30, 2025 | -4,952.00 |
| Sep 30, 2025 | -4,952.00 |
| Jun 30, 2025 | 3,319.00 |
| Jun 30, 2025 | 3,319.00 |
| Mar 31, 2025 | -156,138.00 |
| Mar 31, 2025 | -156,138.00 |
| Dec 31, 2024 | 153,899.00 |
| Dec 31, 2024 | 153,899.00 |
| Sep 30, 2024 | -9,703.00 |
| Sep 30, 2024 | -9,703.00 |
| Jun 30, 2024 | -86,721.00 |
| Jun 30, 2024 | -86,721.00 |
| Mar 31, 2024 | -187,730.00 |
| Mar 31, 2024 | -187,730.00 |
| Dec 31, 2023 | -354,885.00 |
| Dec 31, 2023 | -354,885.00 |